The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Cell cycle, CDKs and cancer: a changing paradigm
Abstract
Tumour-associated cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity. Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability. According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumour cells. However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells. Emerging evidence suggests that tumour cells may also require specific interphase CDKs for proliferation. Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, the demonstration that inactivation of these genes can prevent oncogene-induced tumor development in mouse models reinforced the view that these enzymes might be suitable cancer-specific drug targets (65).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [65]
Citations
Cites
1 retracted
Fasano, C. A., Dimos, J. T., Ivanova, N. B., Lowry, N. A., Lemischka, I. R., & Temple, S. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.04.001 · Cited by 308
RetractedTargeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Patterns of somatic mutation in human cancer genomes
Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,143
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
The spindle-assembly checkpoint in space and time
Musacchio, A., & Salmon, E. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2163 · Cited by 2,227
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,208
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Polyák, K., Lee, M.-H., Erdjument‐Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Polyak, K., Kato, J., Solomon, M., Sherr, C., Massagué, J., Roberts, J., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,949
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B., Walsh, W., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
ATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Genetic Control of the Cell Division Cycle in Yeast
Hartwell, L. H., Culotti, J. G., Pringle, J. R., & Reid, B. J. (1974) · Science · doi:10.1126/science.183.4120.46 · Cited by 1,567
Evans, T., Rosenthal, E. T., Youngblom, J., Distel, D. L., & Hunt, T. (1983) · Cell · doi:10.1016/0092-8674(83)90420-8 · Cited by 1,516
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature reviews. Cancer · doi:10.1038/35106065 · Cited by 1,510
Self-citationMutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,490
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Self-citationUbiquitin ligases: cell-cycle control and cancer
Nakayama, K. I., & Nakayama, K. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1881 · Cited by 1,450
Hematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Mammalian cyclin-dependent kinases
Malumbres, M., & Barbacid, M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.09.005 · Cited by 1,333
Self-citationThe anaphase promoting complex/cyclosome: a machine designed to destroy
Peters, J.-M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1988 · Cited by 1,315
G1 cell-cycle control and cancer
Massagué, J. (2004) · Nature · doi:10.1038/nature03094 · Cited by 1,251
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
On the road to cancer: aneuploidy and the mitotic checkpoint
Kops, G. J. P. L., Weaver, B. A. A., & Cleveland, D. W. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1714 · Cited by 1,201
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N., & Szállási, Z. (2006) · Nature Genetics · doi:10.1038/ng1861 · Cited by 1,199
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,169
Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2
Lee, M. G., & Nurse, P. (1987) · Nature · doi:10.1038/327031a0 · Cited by 1,137
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106
Single-strand break repair and genetic disease
Caldecott, K. W. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2380 · Cited by 1,097
Cdk1 is sufficient to drive the mammalian cell cycle
Santamarı́a, D., Barrière, C., Cerqueira, A., Hunt, S. L., Tardy, C., Newton, K., Cáceres, J. F., Dubus, P. R., Malumbres, M., & Barbacid, M. (2007) · Nature · doi:10.1038/nature06046 · Cited by 1,096
Self-citationDistinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control
van den Heuvel, S., & Harlow, E. (1993) · Science · doi:10.1126/science.8266103 · Cited by 1,092
Lundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,077
Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
Shapiro, G. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7689 · Cited by 1,036
Loda, M. F., Cukor, B., Tam, S. W., Lavin, P. T., Fiorentinc, M., Draetta, G. F., Jessup, J. M., & Pagano, M. (1997) · Nature Medicine · doi:10.1038/nm0297-231 · Cited by 1,031
p16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
Buchkovich, K., Duffy, L. A., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90508-4 · Cited by 995
Sherr, C. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89005-2 · Cited by 980
Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing
Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature05091 · Cited by 972
Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., & Elledge, S. J. (1995) · Genes & Development · doi:10.1101/gad.9.6.650 · Cited by 952
Chen, P.-L., Scully, P., Shew, J.-Y., Wang, J. Y. J., & Lee, W.-H. (1989) · Cell · doi:10.1016/0092-8674(89)90517-5 · Cited by 952
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 916
Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
Lavin, M. F. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2514 · Cited by 901
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
DeCaprio, J. A., Ludlow, J. W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C.-M., & Livingston, D. M. (1989) · Cell · doi:10.1016/0092-8674(89)90507-2 · Cited by 897
Lee, M., Reynisdóttir, I., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.6.639 · Cited by 889
Genetic control of cell size at cell division in yeast
Nurse, P. (1975) · Nature · doi:10.1038/256547a0 · Cited by 868
Targeting polo-like kinase 1 for cancer therapy
Strebhardt, K., & Ullrich, A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1841 · Cited by 849
Genome instability: a mechanistic view of its causes and consequences
Aguilera, A., & Gómez‐González, B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2268 · Cited by 830
Catzavelos, C., Bhattacharya, N., Ung, Y., Wilson, J. A., Roncari, L., Sandhu, C., Shaw, P. H., Yeger, H., Morava‐Protzner, I., Kapusta, L. R., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-227 · Cited by 824
Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast
Lew, D. J., Dulić, V., & Reed, S. I. (1991) · Cell · doi:10.1016/0092-8674(91)90042-w · Cited by 820
Zur Frage der Entstehung maligner Tumoren
Boveri, T. (1914) · Cited by 801
Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice
Ortega, S., Priéto, I., Odajima, J., Martín, A. L., Dubus, P. R., Sotillo, R., Barbero, J. L., Malumbres, M., & Barbacid, M. (2003) · Nature Genetics · doi:10.1038/ng1232 · Cited by 798
Self-citationMammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6
Malumbres, M., Sotillo, R., Santamarı́a, D., Galán, J., Cerezo, A., Ortega, S., Dubus, P., & Barbacid, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.002 · Cited by 793
Self-citationCyclin D-dependent kinases, INK4 inhibitors and cancer
Ortega, S., Malumbres, M., & Barbacid, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00037-9 · Cited by 790
Self-citationChecking on DNA damage in S phase
Bartek, J., Lukas, C., & Lukas, J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1493 · Cited by 758
BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice
Baker, D. J., Jeganathan, K. B., Cameron, J. D., Thompson, M., Juneja, S., Kopecka, A., Kumar, R., Jenkins, R. B., de Groen, P. C., Roche, P., et al. (2004) · Nature Genetics · doi:10.1038/ng1382 · Cited by 731
Aneuploidy Acts Both Oncogenically and as a Tumor Suppressor
Weaver, B. A. A., Silk, A. D., Montagna, C., Verdier-Pinard, P., & Cleveland, D. W. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.003 · Cited by 729
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells
Michel, L. S., Liberal, V., Chatterjee, A., Kirchwegger, R., Pasche, B., Gerald, W. L., Dobles, M., Sorger, P. K., Murty, V. V. V. S., & Benezra, R. (2001) · Nature · doi:10.1038/35053094 · Cited by 725
Kato, J., Matsuoka, M., Polyák, K., Massagué, J., & Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90257-7 · Cited by 720
Guan, K., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C., Matera, A. G., & Xiong, Y. (1994) · Genes & Development · doi:10.1101/gad.8.24.2939 · Cited by 707
Rane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., & Barbacid, M. (1999) · Nature Genetics · doi:10.1038/8751 · Cited by 700
Self-citationCDK8 is a colorectal cancer oncogene that regulates β-catenin activity
Firestein, R., Bass, A. J., Kim, S. Y., Dunn, I. F., Silver, S. J., Guney, I., Freed, E., Ligon, A. H., Vena, N., Ogino, S., et al. (2008) · Nature · doi:10.1038/nature07179 · Cited by 692
Xiong, Y., Connolly, T., Futcher, B., & Beach, D. (1991) · Cell · doi:10.1016/0092-8674(91)90100-d · Cited by 687
Aurora-kinase inhibitors as anticancer agents
Keen, N., & Taylor, S. S. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1502 · Cited by 680
Berthet, C., Aleem, E. A., Coppola, V., Tessarollo, L., & Kaldis, P. (2003) · Current Biology · doi:10.1016/j.cub.2003.09.024 · Cited by 665
Cyclin E Ablation in the Mouse
Geng, Y., Yu, Q., Sicińska, E., Das, M., Schneider, J. E., Bhattacharya, S., Rideout, W. M., Bronson, R. T., Gardner, H., & Siciński, P. (2003) · Cell · doi:10.1016/s0092-8674(03)00645-7 · Cited by 663
Mouse development and cell proliferation in the absence of D-cyclins
Kozar, K., Ciemerych, M. A., Rebel, V. I., Shigematsu, H., Zagozdzon, A., Sicinska, E., Geng, Y., Yu, Q., Bhattacharya, S., Bronson, R. T., et al. (2004) · Cell · doi:10.1016/j.cell.2004.07.025 · Cited by 647
Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B
Hanks, S., Coleman, K., Reid, S., Plaja, A., Firth, H., Fitzpatrick, D., Kidd, A., Méhes, K., Nash, R., Robin, N. H., et al. (2004) · Nature Genetics · doi:10.1038/ng1449 · Cited by 627
Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in Mice
Sotillo, R., Hernando, E., Díaz-Rodríguez, E., Teruya-Feldstein, J., Cordón-Cardo, C., Lowe, S. W., & Benezra, R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.019 · Cited by 612
Cyclin-dependent kinases and cell-cycle transitions: does one fit all?
Hochegger, H., Takeda, S., & Hunt, T. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2510 · Cited by 599
Identification of a Human Mitotic Checkpoint Gene: hsMAD2
Li, Y., & Benezra, R. (1996) · Science · doi:10.1126/science.274.5285.246 · Cited by 597
Wild-type p53 activates transcription in vitro
Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579
Genetic Control of the Cell-Division Cycle in Yeast, I. Detection of Mutants
Hartwell, L. H., Culotti, J. G., & Reid, B. J. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.66.2.352 · Cited by 576
CDK targets Sae2 to control DNA-end resection and homologous recombination
Huertas, P., Cortés‐Ledesma, F., Sartori, A. A., Aguilera, A., & Jackson, S. P. (2008) · Nature · doi:10.1038/nature07215 · Cited by 509
Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.Preprint
Xiong, Y., Zhang, H., & Beach, D. (1993) · Genes & Development · doi:10.1101/gad.7.8.1572 · Cited by 507
Multiple levels of cyclin specificity in cell-cycle control
Bloom, J., & Cross, F. R. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2105 · Cited by 504
Polo on the Rise—from Mitotic Entry to Cytokinesis with Plk1
Petronczki, M. P., Lénárt, P., & Peters, J. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.04.014 · Cited by 503
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells
Carlson, M. E., Hsu, M., & Conboy, I. M. (2008) · Nature · doi:10.1038/nature07034 · Cited by 498
CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair
Esashi, F., Christ, N., Gannon, J., Liu, Y., Hunt, T., Jasin, M., & West, S. C. (2005) · Nature · doi:10.1038/nature03404 · Cited by 473
Proliferation of cancer cells despite CDK2 inhibition
Tetsu, O., & McCormick, F. P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00053-9 · Cited by 472
Kippin, T. E., Martens, D. J., & van der Kooy, D. (2005) · Genes & Development · doi:10.1101/gad.1272305 · Cited by 442
Requirement for CDK4 kinase function in breast cancer
Yu, Q., Sicinska, E., Geng, Y., Ahnström, M., Zagozdzon, A., Kong, Y., Gardner, H., Kiyokawa, H., Harris, L. N., Stål, O., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.012 · Cited by 429
Choudhury, A. R., Ju, Z., Djojosubroto, M. W., Schienke, A., Lechel, A., Schaetzlein, S., Jiang, H., Stepczynska, A., Wang, C., Buer, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1937 · Cited by 426
NFATc1 Balances Quiescence and Proliferation of Skin Stem Cells
Horsley, V., Aliprantis, A. O., Polak, L., Glimcher, L. H., & Fuchs, E. (2008) · Cell · doi:10.1016/j.cell.2007.11.047 · Cited by 424
Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27 Kip1 Activity
Tsutsui, T., Hesabi, B., Moons, D. S., Pandolfi, P. P., Hansel, K. S., Koff, A., & Kiyokawa, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7011 · Cited by 395
Cdc2–cyclin E complexes regulate the G1/S phase transition
Aleem, E. A., Kiyokawa, H., & Kaldis, P. (2005) · Nature Cell Biology · doi:10.1038/ncb1284 · Cited by 383
Finishing mitosis, one step at a time
Sullivan, M., & Morgan, D. O. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2276 · Cited by 375
Secrets of a double agent: CDK7 in cell-cycle control and transcription
Fisher, R. P. (2005) · Journal of Cell Science · doi:10.1242/jcs.02718 · Cited by 371
Genomic stability and tumour suppression by the APC/C cofactor Cdh1
García-Higuera, I., Manchado, E., Dubus, P. R., Cañamero, M., Méndez, J., Moreno, S., & Malumbres, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1742 · Cited by 357
Self-citationZur Frage der Entstehung maligner Tumoren
Ribbert, H., & Bally, W. (1914) · Die Naturwissenschaften · doi:10.1007/bf01497322 · Cited by 342
Malumbres, M., & Barbacid, M. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.008 · Cited by 338
Self-citationRescue of Cyclin D1 Deficiency by Knockin Cyclin E
Geng, Y., Whoriskey, W. J., Park, M. Y., Bronson, R. T., Medema, R. H., Li, T., Weinberg, R. A., & Siciński, P. (1999) · Cell · doi:10.1016/s0092-8674(00)80788-6 · Cited by 336
Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis
Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., & Hinds, P. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.019 · Cited by 329
Cyclin C/Cdk3 Promotes Rb-Dependent G0 Exit
Ren, S., & Rollins, B. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00300-9 · Cited by 326
Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts.
Pagano, M., Pepperkok, R., Lukáš, J., Baldin, V., Ansorge, W., Bártek, J., & Draetta, G. F. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.121.1.101 · Cited by 322
Oncogenes and tumour suppressors take on centrosomes
Fukasawa, K. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2249 · Cited by 320
E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8
Morris, E. J., Ji, J., Yang, F., Stefano, L. D., Herr, A., Moon, N. S., Kwon, E. J., Haigis, K. M., Näär, A. M., & Dyson, N. J. (2008) · Nature · doi:10.1038/nature07310 · Cited by 306
CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?
Antoni, L., Sodha, N., Collins, I., & Garrett, M. D. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2251 · Cited by 296
Slippage of Mitotic Arrest and Enhanced Tumor Development in Mice with BubR1 Haploinsufficiency
Dai, W. H., Wang, Q., Liu, T., Swamy, M. V., Fang, Y., Xie, S., Mahmood, R., Yang, Y., Xu, M., & Rao, C. V. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3119 · Cited by 291
Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero
Brandeis, M., Rosewell, I. R., Carrington, M., Crompton, T., Jacobs, M. A., Kirk, J. A., Gannon, J., & Hunt, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4344 · Cited by 290
Delayed early embryonic lethality following disruption of the murine cyclin A2 gene
Murphy, M., Stinnakre, M., Sénamaud‐Beaufort, C., Winston, N. J., Sweeney, C., Kubelka, M., Carrington, M., Bréchot, C., & Sobczak‐Thépot, J. (1997) · Nature Genetics · doi:10.1038/ng0197-83 · Cited by 279
Larochelle, S., Merrick, K. A., Terret, M., Wohlbold, L., Barboza, N. M., Zhang, C., Shokat, K. M., Jallepalli, P. V., & Fisher, R. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.003 · Cited by 272
Yuan, Y., Shen, H., Franklin, D. S., Scadden, D. T., & Cheng, T. (2004) · Nature Cell Biology · doi:10.1038/ncb1126 · Cited by 269
Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells
Parisi, T., Beck, A. R., Rougier, N., McNeil, T., Lucian, L., Werb, Z., & Amati, B. B. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg482 · Cited by 269
CDK inhibitors in cancer therapy: what is next?
Malumbres, M., Pevarello, P., Barbacid, M., & Bischoff, J. R. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.012 · Cited by 240
Self-citationIorns, E. J., Turner, N. C., Elliott, R. J. R., Syed, N., Garrone, O., Gasco, M., Tutt, A. N. J., Crook, T., Lord, C. J., & Ashworth, A. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.001 · Cited by 230
Jeganathan, K. B., Malureanu, L. A., Baker, D. J., Abraham, S. C., & van Deursen, J. M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200706015 · Cited by 226
Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1
Martín, A., Odajima, J., Hunt, S. L., Dubus, P. R., Ortega, S., Malumbres, M., & Barbacid, M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.006 · Cited by 223
Self-citationA census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy
de Castro, I. P., de Cárcer, G., & Malumbres, M. (2006) · Carcinogenesis · doi:10.1093/carcin/bgm019 · Cited by 222
Self-citation14-3-3σ controls mitotic translation to facilitate cytokinesis
Wilker, E., van Vugt, M. A. T. M., Artim, S. C., Huang, P. H., Petersen, C. P., Reinhardt, H. C., Feng, Y., Sharp, P. A., Sonenberg, N., White, F. M., et al. (2007) · Nature · doi:10.1038/nature05584 · Cited by 217
Wide spectrum of tumors in knock‐in mice carrying a Cdk4 protein insensitive to INK4 inhibitors
Sotillo, R., Dubus, P., Martn, J., de la Cueva, E., Ortega, S., Malumbres, M., & Barbacid, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6637 · Cited by 208
Self-citationBesson, A., Hwang, H. C., Cicero, S. A., Donovan, S. L., Gurian-West, M., Johnson, D. A., Clurman, B. E., Dyer, M. A., & Roberts, J. M. (2007) · Genes & Development · doi:10.1101/gad.1556607 · Cited by 208
Aneuploidy: Instigator and Inhibitor of Tumorigenesis
Weaver, B. A. A., & Cleveland, D. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2266 · Cited by 199
The reversibility of mitotic exit in vertebrate cells
Potapova, T., Daum, J. R., Pittman, B. D., Hudson, J. R., Jones, T. N., Satinover, D. L., Stukenberg, P. T., & Gorbsky, G. J. (2006) · Nature · doi:10.1038/nature04652 · Cited by 190
Role of CDK/cyclin complexes in transcription and RNA splicing
Loyer, P., Trembley, J. H., Katona, R. L., Kidd, V. J., & Lahti, J. M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.02.005 · Cited by 189
Kinase-independent function of cyclin E
Geng, Y., Lee, Y.-M., Welcker, M., Swanger, J., Zagozdzon, A., Winer, J. D., Roberts, J. M., Kaldis, P., Clurman, B. E., & Sicinski, P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.11.029 · Cited by 187
Cdc20 and Cks Direct the Spindle Checkpoint-Independent Destruction of Cyclin A
Wolthuis, R. M. F., Clay-Farrace, L., van Zon, W., Yekezare, M., Koop, L., Ogink, J., Medema, R. H., & Pines, J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.027 · Cited by 177
An essential role for Cdk1 in S phase control is revealed via chemical genetics in vertebrate cells
Hochegger, H., Dejsuphong, D., Sonoda, E., Saberi, A., Rajendra, E., Kirk, J. A., Hunt, T., & Takeda, S. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200702034 · Cited by 170
Rane, S. G., Cosenza, S. C., Mettus, R. V., & Reddy, E. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.644-656.2002 · Cited by 167
Invasive melanoma in Cdk4-targeted mice
Sotillo, R., García, J. F., Ortega, S., Martín‐Broto, J., Dubus, P. R., Barbacid, M., & Malumbres, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241338598 · Cited by 164
Self-citationEarly mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C
Hayes, M. J., Kimata, Y., Wattam, S. L., Lindon, C., Mao, G., Yamano, H., & Fry, A. M. (2006) · Nature Cell Biology · doi:10.1038/ncb1410 · Cited by 160
Pho85, a multifunctional cyclin‐dependent protein kinase in budding yeast
Huang, D., Friesen, H., & Andrews, B. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05914.x · Cited by 158
Li, M., Shin, Y.-H., Hou, L., Huang, X., Wei, Z., Klann, E., & Zhang, P. (2008) · Nature Cell Biology · doi:10.1038/ncb1768 · Cited by 156
Cell cycle in mouse development
Ciemerych, M. A., & Siciński, P. (2005) · Oncogene · doi:10.1038/sj.onc.1208608 · Cited by 154
Combined Loss of Cdk2 and Cdk4 Results in Embryonic Lethality and Rb Hypophosphorylation
Berthet, C., Klarmann, K. D., Hilton, M. B., Suh, H. C., Keller, J. R., Kiyokawa, H., & Kaldis, P. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.004 · Cited by 152
Chen, H.-H., Wang, Y.-C., & Fann, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2736-2745.2006 · Cited by 144
Cdk-counteracting phosphatases unlock mitotic exit
Queralt, E., & Uhlmann, F. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.09.003 · Cited by 143
Bub1 Maintains Centromeric Cohesion by Activation of the Spindle Checkpoint
Perera, D., Tilston, V., Hopwood, J. A., Barchi, M., Boot-Handford, R., & Taylor, S. S. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.08.008 · Cited by 143
Mantel, C., Guo, Y., Lee, M. R., Kim, M.-K., Han, M., Shibayama, H., Fukuda, S., Yöder, M. C., Pelus, L. M., Kim, K.-S., et al. (2007) · Blood · doi:10.1182/blood-2006-10-054247 · Cited by 136
The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation
Petretti, C., Savoian, M. S., Montembault, É., Glover, D. M., Prigent, C., & Giet, R. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400639 · Cited by 134
Lü, X., Park, S. H., Thompson, T. C., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90541-j · Cited by 132
Polo and Aurora kinases — lessons derived from chemical biology
Taylor, S. S., & Peters, J. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.11.008 · Cited by 131
Hematopoietic stem cell exhaustion impacted by p18INK4C and p21Cip1/Waf1 in opposite manners
Yu, H., Yuan, Y., Shen, H., & Cheng, T. (2006) · Blood · doi:10.1182/blood-2005-02-0685 · Cited by 127
Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity
Maestre, C., Delgado‐Esteban, M., Sánchez, J. C. G., Bolaños, J. P., & Almeida, Á. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.195 · Cited by 126
Mice thrive without Cdk4 and Cdk2
Barrière, C., Santamarı́a, D., Cerqueira, A., Galán, J., Martín, A. L., Ortega, S., Malumbres, M., Dubus, P. R., & Barbacid, M. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.03.001 · Cited by 125
Self-citationMartín, J., Hunt, S. L., Dubus, P., Sotillo, R., Néhmé-Pélluard, F., Magnuson, M. A., Parlow, A. F., Malumbres, M., Ortega, S., & Barbacid, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206506 · Cited by 122
Self-citationThe ubiquitin ligase APCCdh1 is required to maintain genome integrity in primary human cells
Engelbert, D., Schnerch, D., Baumgarten, A., & Wäsch, R. (2007) · Oncogene · doi:10.1038/sj.onc.1210703 · Cited by 115
Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons
Zhang, J., Cicero, S. A., Wang, L., Romito-DiGiacomo, R. R., Yang, Y., & Herrup, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711355105 · Cited by 113
Walkley, C. R., Fero, M. L., Chien, W., Purton, L. E., & McArthur, G. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1214 · Cited by 112
Duensing, A. U., Liu, Y., Tseng, M., Malumbres, M., Barbacid, M., & Duensing, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209310 · Cited by 107
Self-citationA premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene
Ye, X., Zhu, C., & Harper, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1682 · Cited by 105
Cyclin-Dependent Kinase 4 Expression Is Essential for Neu-Induced Breast Tumorigenesis
Reddy, H. K. D. L., Mettus, R. V., Rane, S. G., Graña, X., Litvin, J., & Reddy, E. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2639 · Cited by 105
Pechnick, R. N., Zonis, S., Wawrowsky, K., Pourmorady, J., & Chesnokova, V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711030105 · Cited by 103
Lack of Cyclin-Dependent Kinase 4 Inhibits c- myc Tumorigenic Activities in Epithelial Tissues
de Marval, P. L. M., Macias, E., Rounbehler, R. J., Siciński, P., Kiyokawa, H., Johnson, D. G., Conti, C. J., & Rodríguez‐Puebla, M. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7538-7547.2004 · Cited by 100
Mettus, R. V., & Rane, S. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206888 · Cited by 97
CDK11p58 is required for the maintenance of sister chromatid cohesion
Hu, D., Valentine, M. B., Kidd, V. J., & Lahti, J. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.007963 · Cited by 96
Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Malumbres, M., & Barbacid, M. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.026 · Cited by 96
Self-citationJablonska, B., Aguirre, A. A., Vandenbosch, R., Belachew, S. M., Berthet, C., Kaldis, P., & Gallo, V. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200702031 · Cited by 92
Cdk11 is a RanGTP-dependent microtubule stabilization factor that regulates spindle assembly rate
Yokoyama, H., Gruß, O. J., Rybina, S., Caudron‐Herger, M., Schelder, M., Wilm, M. S., Mattaj, I. W., & Karsenti, E. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200706189 · Cited by 89
Control of G2 delay by the RAD9 gene of Saccharomyces cerevisiae
Weinert, T. A., & Hartwell, L. H. (1989) · Journal of Cell Science · doi:10.1242/jcs.1989.supplement_12.12 · Cited by 87
Li, T., Inoue, A., Lahti, J. M., & Kidd, V. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3188-3197.2004 · Cited by 86
CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing
Chen, H.-H., Wong, Y., Genevière, A., & Fann, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.049 · Cited by 83
Ande, S., Berthet, C., Lopez-Molina, J., Coppola, V., Tessarollo, L., & Kaldis, P. (2008) · Development · doi:10.1242/dev.024919 · Cited by 79
Cdk4 Is Indispensable for Postnatal Proliferation of the Anterior Pituitary
Jirawatnotai, S., Aziyu, A., Osmundson, E. C., Moons, D. S., Zou, X., Kineman, R. D., & Kiyokawa, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409080200 · Cited by 76
CDK activation by non-cyclin proteins
Nebreda, Á. R. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.01.001 · Cited by 75
Pituitary Hypoplasia and Lactotroph Dysfunction in Mice Deficient for Cyclin-Dependent Kinase-4
Moons, D. S., Jirawatnotai, S., Parlow, A. F., Gibori, G., Kineman, R. D., & Kiyokawa, H. (2002) · Endocrinology · doi:10.1210/endo.143.8.8956 · Cited by 71
Dual role of CDKs in DNA repair: To be, or not to be
Yata, K., & Esashi, F. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.002 · Cited by 62
Emerging cancer therapeutic opportunities by inhibiting mitotic kinases
de Castro, I. P., de Cárcer, G., Montoya, G., & Malumbres, M. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.013 · Cited by 58
Self-citationRoles of cyclins A and E in induction of centrosome amplification in p53-compromised cells
Hanashiro, K., Kanai, M., Geng, Y., Siciński, P., & Fukasawa, K. (2008) · Oncogene · doi:10.1038/onc.2008.161 · Cited by 55
Sotillo, R., Renner, O., Dubus, P. R., Ruı́z-Cabello, J., Martín‐Caballero, J., Barbacid, M., Carnero, A., & Malumbres, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4195 · Cited by 53
Self-citationPei, X., Bai, F., Smith, M. D., & Xiong, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4517 · Cited by 45
Rosu‐Myles, M., Taylor, B. J., & Wolff, L. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.11.005 · Cited by 35
Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice
Chandramouli, A., Shi, J., Feng, Y., Holubec, H., Shañas, R., Bhattacharyya, A. K., Zheng, W., & Nelson, M. A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm066 · Cited by 25
Yuen, K. W. Y., & Desai, A. B. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801030 · Cited by 15
Synchronicity: policing multiple aspects of gene expression by Ctk1: Figure 1.Preprint
Hampsey, M., & Kinzy, T. G. (2007) · Genes & Development · doi:10.1101/gad.1564807 · Cited by 6
Flagged first, then by citations
Research works printed but not linked: 1
- Hanks, S. et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nature Genet. 36, 1159–1161 (2004). · DOI
Cited by
Sorted by citations
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
“CDK1, at least in some tissues, may be the crucial target of p21 in tumorigenesi”
BackgroundMonitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Programmed Cell Death in Animal Development and Disease
Fuchs, Y., & Steller, H. (2011) · Cell · doi:10.1016/j.cell.2011.10.033 · Cited by 1,915
“Other examples include the elimination of cells in response to viral infection, unrepaired DNA damage, cellcycle perturbations, and fate and differentiation defects (Abrams et al., 1993; Rossel and Capecchi, 1999; Derry et al., 2001, Vousden and Prives, 2009; Malumbres and Barbacid, 2009; Koto et al., 2011).”
Finn, R. S., Crown, J. P., Lang, I., Boer, K., Bondarenko, I. M., Kulyk, S. O., Ettl, J., Patel, R., Pinter, T., Schmidt, M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71159-3 · Cited by 1,900
Cell cycle proteins as promising targets in cancer therapy
Otto, T., & Siciński, P. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2016.138 · Cited by 1,931
“Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.”
Metadata
- Authors
- Malumbres, M., & Barbacid, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Venue
- Nature Reviews Cancer
- Published
- 2009-03
- Volume
- 9
- Issue
- 3
- Pages
- 153-166
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2046024621
- Cited by
- 3,957
- References
- 178
- Citations by year
- 2026: 191 · 2025: 241 · 2024: 266 · 2023: 277 · 2022: 297 · 2021: 318 · 2020: 272 · 2019: 222 · 2018: 237 · 2017: 260 · 2016: 195 · 2015: 228 · 2014: 218 · 2013: 206 · 2012: 186
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- cyclin-dependent kinases, CDK1, cell cycle, tumor cell proliferation, genomic instability, chromosomal instability, cyclin-dependent kinase inhibitors, selective cancer therapy
- MeSH terms
- Animals, Cell Cycle, Chromosome Aberrations, DNA Damage, Humans, Mitosis, Neoplasms, Neoplastic Stem Cells, Cyclins, Cyclin-Dependent Kinases, Cyclin E, Chromosomal Instability, Protein Kinase Inhibitors, Cell Proliferation, Cyclin D
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review